PSSR Games List for PS5 Pro: Native 2.0 and Upgradeable 1.0 Titles

PSSR 2.0 was released on March 16, 2026 and — built as an AMD FSR 4 fork under the AMD–Sony Project Amethyst collaboration — materially improves temporal stability and image clarity versus PSSR 1.0. Sixteen PS5 Pro games have been patched natively for PSSR 2.0, and dozens of PSSR 1.0 titles can be upgraded system-wide via a toggle (Sony warns some titles may show visual issues). Mark Cerny states the toggle will currently point to PSSR 2.0, and a version of AMD FSR Frame Generation is scheduled for future PlayStation support.

Analysis

The PSSR 2.0 rollout and the system-level toggle materially change marginal value calculations for the PS5 Pro hardware ecosystem: improving installed-base image quality via a firmware switch compresses the developer upgrade burden and raises the effective attach-rate of perceived ‘Pro-grade’ titles without equivalent hardware R&D spend. That raises Sony’s service/monetization optionality over the next 12–24 months — higher engagement + visible quality improvements increase DLC/live-service retention rates and reduce reasons for early replacement cycles among console owners.

Strategically, the AMD–Sony collaboration (Project Amethyst) is a force-multiplier for AMD’s software/IP positioning in gaming, improving AMD’s bargaining leverage for future console SoC deals and giving AMD a beachhead in temporal/AI upscaling on a major platform. Second-order, broader PC GPU upgrade demand could soften if console upscaling and future frame-generation meaningfully close the visual/temporal gap versus high-end PC rendering — a multi-quarter headwind to premium discrete GPU cycle intensity that favors cheaper console-optimized silicon over top-end GPU ASPs.

Key risks: developer pushback and visual regressions from auto-upgraded titles could slow adoption and trigger negative consumer sentiment within weeks of toggling; conversely, delayed or buggy frame-generation rollout would postpone the biggest long-term usability benefit for consumers and OEMs. Regulatory/IP or licensing frictions around the AMD fork, or a strategic counter from rival middleware providers, could reverse software-led benefits over 6–18 months and compress expected alpha for AMD/Sony.

Time framing matters: expect stock reactions in days around patch announcements and earnings guidance, but durable revenue effects play out over 6–24 months as more titles are natively patched and potential frame-generation is rolled in. Monitor three near-term catalysts that will re-rate these names: (1) patch cadence for top-20 console titles over next 3 months, (2) evidence of user-reported visual regressions within 30–90 days, and (3) Sony/AMD disclosures on commercial terms of Project Amethyst or future frame-generation timelines within the next 6–12 months.

Key Decisions for Investors

• Long SONY (6–12 months): Buy a 12-month call spread (ATM to +15–20% strike) sized to 2–3% portfolio exposure. Thesis: services + higher perceived value from system-level upgrades re-rate growth; target +25–35% upside, stop -10–12% on adverse guidance or clear negative consumer sentiment on upgrades.
• Long AMD (12–24 months): Buy 18-month LEAP calls or a bull call spread to capture continuing console software/IP wins and potential uplift to console SoC economics. Risk/reward: asymmetric upside (2–3x) if Project Amethyst becomes a recurring commercial advantage; cut position on evidence of licensing/legal challenges or if AMD guidance implies no material console revenue lift within 2 quarters.
• Relative pair — Long AMD / Short NVDA (6–12 months, modest size): Size 0.5–0.7x NVDA notional to express console/software-led upside vs. NVDA’s heavier datacenter/PC GPU exposure. Rationale: console wins and FSR-derived stack favor AMD in gaming; hedge datacenter-driven idiosyncratic risk in NVDA. Limit max drawdown to 8–10% by dynamic rebalancing.
• Event-driven options: Buy short-dated (30–90 day) call calendar on SONY or AMD ahead of major developer conferences / earnings to capture positive re-rating from patch rollouts, while selling shorter-dated premium to finance cost. Risk: rapid IV collapse if nothing materializes; cap position to <1.5% portfolio.